• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Ada Garrido Benavidez, Mexico

    Ada Garrido Benavidez, Mexico

  • Inta Grubb, Australia

    Inta Grubb, Australia

  • Joanne Pratt, Australia

    Joanne Pratt, Australia

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • Brian Parsons, Canada

    Brian Parsons, Canada

  • Ali Var, Turkey

    Ali Var, Turkey

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Maria Santos Garcia Tellez, Mexico

    Maria Santos Garcia Tellez, Mexico

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • Ian Gale, Australia

    Ian Gale, Australia

  • Jo Knowlton, Scotland

    Jo Knowlton, Scotland

  • Yessenia Hernandez Mendoza, Mexico

    Yessenia Hernandez Mendoza, Mexico

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Olga, Argentina

    Olga, Argentina

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Anita Forte, USA

    Anita Forte, USA

  • Timmy, Belgium

    Timmy, Belgium

  • Oscar Mauricio Linares, Colombia

    Oscar Mauricio Linares, Colombia

  • Jorge Melo, Brazil

    Jorge Melo, Brazil

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Alex, Argentina

    Alex, Argentina

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Jose Rivero Muñoz, Mexico

    Jose Rivero Muñoz, Mexico

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Karl Hughes, Ireland

    Karl Hughes, Ireland

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Yannick Richard, Canada

    Yannick Richard, Canada
    yannickrichard

  • Lee Millard, England

    Lee Millard, England

  • Daniel Hare, USA

    Daniel Hare, USA

  • Richard Clark, New Zealand

    Richard Clark, New Zealand

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • David Solomon, UK

    David Solomon, UK

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Jason Goodman, USA

    Jason Goodman, USA

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login